Carl-Henric Heldin, Staffan Johansson and Gunnar Pejler have been awarded a total of 10.6 million SEK by the Swedish Cancer Society, Cancerfonden


Cancerfonden has decided to give an additional SEK 670 million to Swedish cancer research. This means that the Swedish Cancer Society decided this year on a record dividend of SEK 770 million. It is the largest amount in the history of the Swedish Cancer Society.

Research projects that will receive funding for their research are:
Carl-Henrik Heldin, Uppsala universitet, PDGF receptor signaling - importance of receptor trafficking and localization, 2020-01-01 - 2022-12-31, 3 år x 1 250 000 Skr

Staffan Johansson, Uppsala universitet, CYTOKINESIS AS A CANCER-SPECIFIC TARGET, 2020-01-01 - 2022-12-31, 3 år x 800 000 Skr

Sven Pejler, Uppsala universitet, The role of mast cells in cancer- experimental and clinical aspects, 2020-01-01 - 2022-12-31, 3 år x 1 500 000 Skr

Read more about the Swedish Cancer Society, Cancerfonden (only in Swedish)